Free Trial

Arcus Biosciences (RCUS) SEC Filings & 10K Form

Arcus Biosciences logo
$9.04 +0.27 (+3.02%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$9.02 -0.02 (-0.22%)
As of 05/23/2025 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Arcus Biosciences SEC Filings

DateFilerForm TypeView
05/13/2025
4:57 PM
Arcus Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
02/27/2025
6:05 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:06 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:42 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
6:43 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SCHEDULE 13D/A
02/19/2025
3:05 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
5:44 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:10 PM
Arcus Biosciences (Issuer)
Markus Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2025
8:10 PM
Arcus Biosciences (Issuer)
Markus Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
4:02 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:29 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:30 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:31 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:10 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
8:52 PM
Arcus Biosciences (Subject)
ROSEN TERRY J (Filed by)
Form SC 13D/A
12/17/2024
7:35 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:36 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
7:37 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
3:23 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:25 PM
Arcus Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:11 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:31 AM
Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
09/17/2024
5:42 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:42 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:12 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:45 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:53 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:19 PM
Arcus Biosciences (Issuer)
Lambert Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking discovery could help you target payouts on weekends… (Ad)

Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...

06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:21 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:28 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
7:18 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:RCUS) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners